T1	Participants 79 121	HIV-associated B-cell non-Hodgkin lymphoma
T2	Participants 198 261	immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL)
T3	Participants 347 365	HIV-associated NHL
T4	Participants 713 731	HIV-associated NHL
T5	Participants 956 1023	35 of 48 evaluable patients (73%; 95% confidence interval, 58%-85%)
T6	Participants 1072 1139	29 of 53 evaluable patients (55%; 95% confidence interval, 41%-68%)
T7	Participants 1280 1334	patients with a baseline CD4 count less than 50/microL
T8	Participants 1479 1502	HIV-associated lymphoma
